<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Qiagen N.V. Press Releases </title><link>https://corporate.qiagen.com/</link><description>generated by Q4</description><category /><lastBuildDate>Sun, 10 May 2026 13:10:42 -0400</lastBuildDate><copyright>Copyright Q4 Inc. All rights reserved.</copyright><item><title>QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing</title><guid>62b1f5f7-9e25-4f0a-9780-ffe98b341682</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Plans-to-Launch-New-Fully-Automated-Sample-to-Insight-Workflow-and-an-AI-Enabled-Risk-Stratification-Tool-to-Advance-QuantiFERON-Latent-TB-Testing/default.aspx</link><pubDate>Thu, 07 May 2026 06:00:00 -0400</pubDate></item><item><title>QIAGEN Reports Full Results for Q1 2026</title><guid>ba8a1693-ea2f-4b13-8e0a-450ce26d209b</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Reports-Full-Results-for-Q1-2026/default.aspx</link><pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate></item><item><title>QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook</title><guid>f2aa604d-aa00-41bf-9bb4-7c843db2d8c3</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-reports-preliminary-Q1-2026-results-achieves-adjusted-EPS-outlook-with-mixed-sales-trends-updates-full-year-2026-outlook/default.aspx</link><pubDate>Mon, 27 Apr 2026 16:16:00 -0400</pubDate></item><item><title>QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026</title><guid>70f5c8a9-3afa-4b1f-8a4a-88ee778a2888</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-to-Showcase-New-Sample-to-Insight-Solutions-for-Complex-Oncology-Applications-at-AACR-2026/default.aspx</link><pubDate>Thu, 16 Apr 2026 16:05:00 -0400</pubDate></item><item><title>QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel</title><guid>e9c2a6f8-3d43-40f3-b2bf-7fc0eb56a65b</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Expands-Into-Bloodstream-Infection-Syndromic-Testing-With-New-Rapid-QIAstat-Dx-Panel/default.aspx</link><pubDate>Tue, 14 Apr 2026 16:05:00 -0400</pubDate></item><item><title>QIAGEN Announces Form 20-F Annual Report Filing for 2025 Results</title><guid>d4189e49-4b1e-4ef0-bda1-7e619676c00d</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/Qiagen-Announces-Form-20-F-Annual-Report-Filing-for-2025-Results/default.aspx</link><pubDate>Fri, 20 Mar 2026 07:30:00 -0400</pubDate></item><item><title>QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention</title><guid>37b8b56b-8202-4fa8-8494-6afe4b971a8c</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Highlights-Newly-Published-Data-Supporting-Efficacy-of-QuantiFERON-for-TB-Prevention/default.aspx</link><pubDate>Thu, 19 Mar 2026 16:05:00 -0400</pubDate></item><item><title>QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System</title><guid>10b088c8-59df-4edb-88fa-bc82129aa4ff</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Receives-U-S--Clearance-for-Gastrointestinal-Panels-on-Fully-Automated-QIAstat-Dx-Rise-Syndromic-Testing-System/default.aspx</link><pubDate>Tue, 10 Mar 2026 17:05:00 -0400</pubDate></item><item><title>Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery</title><guid>52ea8c23-5f9c-4c8d-b6a7-f4123208ba24</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/Parse-Biosciences-Launches-Evercode-Whole-Transcriptome-V4-With-Shorter-Workflow-Higher-Sensitivity-and-Higher-Cell-Recovery/default.aspx</link><pubDate>Thu, 19 Feb 2026 08:00:00 -0500</pubDate></item><item><title>QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars</title><guid>2afc6522-92d0-4bd8-9a91-ca0cdfcdb2bd</guid><description /><link>https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Exceeds-Q4-2025-Outlook-Driven-by-Growth-Pillars/default.aspx</link><pubDate>Wed, 04 Feb 2026 16:05:00 -0500</pubDate></item></channel></rss>